iwCLL 2023 | Defining success in CLL
In this interview, Lydia Scarfò, MD, Vita-Salute San Raffaele University & IRCCS San Raffaele Scientific Institute, Milan, Italy, comments on a session about defining success in chronic lymphocytic leukemia (CLL) held at the 2023 International Workshop on Chronic Lymphocytic Leukemia (iwCLL). In this session, important goals for the future of CLL were identified, including identifying which therapies are beneficial for patients earlier, through observing factors such as measurable residual disease, immune function, and quality of life. This interview was recorded at the biennial iwCLL 2023 meeting, held in Boston, MA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Disclosures
Advisory board: AbbVie, AstraZeneca, BeiGene, Janssen, Lilly
Speaker bureau: Octapharma
